Clinical Trial Participation: A Gilchrist Family Mission
This article was written by Amanda Gilchrist, a Participant Advisory Council Member (PAC), a Clinical Trial Education Volunteer, and Breakthrough T1D supporter. Amanda’s story details her family’s type 1 diabetes (T1D) journey, why clinical trial participation is important to her, and her experience in the PAC. The views expressed by the author are her own […]
International Experts Advance Clinical Adoption of Islet Cell Therapies at Breakthrough T1D HQ
Islet cell therapies for type 1 diabetes (T1D) replace destroyed insulin-producing beta cells with functional cells that allow the body to make insulin again. To ensure there are enough islet cells for everyone with T1D who wants them, Breakthrough T1D is prioritizing manufactured cell therapies, which can be made in large quantities in a laboratory, […]
An Interview with Vertex
It’s an exciting time for type 1 diabetes (T1D) research. Nearly every day, we’re seeing incredible progress across each area of Breakthrough T1D’s research portfolio to cure, prevent, and treat T1D and its complications. One area in particular is making headlines: Cell therapies. In T1D, the immune system destroys the beta cells in the pancreas, which produce insulin. Cell therapies aim to replace […]
Balancing Mental Health and Type 1 Diabetes
Taking care of your mental health with type 1 diabetes is just as important as managing your blood sugar and taking your insulin.
C-peptide: Everything You Need to Know
It was identified in the late 1960s. Since then, studies have shown that it is a biomarker for beta cell function. In other words, it’s a measure of beta cell health and insulin production. If it’s low (or you have none), it indicates that your pancreas is producing little or no insulin. There was even […]
Tzield Approved for Children Ages One and Older in Stage 2 T1D
What’s happening? The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. This is a huge win for the T1D community! Breakthrough T1D applauds the FDA for this approval and Sanofi for their commitment to new therapies for the T1D […]
Two Highly Engaged Volunteer Leaders Elected to Head Breakthrough T1D’s International Board of Directors
Karen Shishino Jordan, a long-time volunteer leader in the greater California Bay area, will serve as Breakthrough T1D (formerly JDRF) International Board of Directors (IBOD) Chair, succeeding current Chair Lisa Fishbone Wallack. Carlton McMillan, also a dedicated volunteer leader in the greater California Bay area, will serve as Vice Chair, succeeding current Vice Chair Matt Varey. Karen’s and Carlton’s terms as Chair and Vice Chair, respectively, begin Wednesday, July 1, 2026. Breakthrough […]
Heroes of Time: How 33 Creators Joined Forces to Raise Money for T1D Cures
Remember how fun it was to be on the couch with your friends, fire up your Nintendo console, and play video games late into the night? Heroes of Time captures that magic but adds in 33 talented creators, a massive audience, and creative fundraising. It’s all in support of Breakthrough T1D Play and our work […]
There’s a Breakthrough T1D Ride for You: Tips and Tricks from Veteran Participants
Breakthrough T1D Ride is a charitable cycling event that has raised over $77 million for type 1 diabetes (T1D) research, which has directly led to innovations like continuous glucose monitors (CGMs) and disease-modifying therapies that can slow the progression of T1D. Ride offers cyclists of every age and skill level the chance to fuel breakthroughs […]
Our Volunteers Make Breakthrough T1D Walk Happen: Spotlight on Casey Adams
Breakthrough T1D Walk is a nationwide movement dedicated to raising type 1 diabetes (T1D) awareness and funding research. As the largest T1D walk, this event empowers individuals and teams to take action. But we couldn’t do it alone—our local volunteers make each event possible! That includes Casey Adams, Corporate Committee Co-Chair for the Los Angeles […]
